Data processing: measuring – calibrating – or testing – Measurement system in a specific environment – Biological or biochemical
Reexamination Certificate
2011-08-30
2011-08-30
Moran, Marjorie (Department: 1631)
Data processing: measuring, calibrating, or testing
Measurement system in a specific environment
Biological or biochemical
C435S004000
Reexamination Certificate
active
08010295
ABSTRACT:
A technique is disclosed for classifying a population of subjects into various sub-populations for a selected biological condition. Patients are categorized in accordance with numeric scores for a affected status for the selected biological condition and a risk status for the selected biological condition. The numeric scores for an overall population are determined in advance for the selected biological condition. Medical test results, including genetic tests, and risk factors are numerically scored and may further be weighted in accordance with their relevance in determining affected status and risk. Medical test results and medical histories for individual subjects within the population may then automatically be scored in accordance with the predefined characteristics. The numerical scores for affected status and risk status may be stored in a data structure, such as a database. The numeric scores are extracted from the data structure and used to classify individuals in the population into one of a group of selected sub-populations comprising at-risk affected (ARA) and at-risk unaffected (ARU). Additional sub-populations, such as unknown risk, unaffected (URU) may also be used.
REFERENCES:
patent: 4863873 (1989-09-01), Matson
patent: 5387506 (1995-02-01), Blumenfeld et al.
patent: 5753441 (1998-05-01), Skolnick et al.
patent: 5953727 (1999-09-01), Maslyn et al.
patent: 5966711 (1999-10-01), Adams
patent: 6023659 (2000-02-01), Seilhamer et al.
patent: 6059724 (2000-05-01), Campell et al.
patent: 6130042 (2000-10-01), Diehl et al.
patent: 6558955 (2003-05-01), Kristal et al.
patent: WO 93/12255 (1993-06-01), None
patent: WO 00/51053 (2000-08-01), None
“Susceptibility to Breast Cancer,” Clinical Study sponsored by National Cancer Institute (NCI) started on Feb. 8, 2000, [retrieved from Internet].
“Genetic Testing for Breast Cancer Risk: It's Your Choice,” NCI, Aug. 14, 1997, [retrieved from Internet].
Schwartz et al. “Risk Communication in Clinical Practice: Putting Cancer in Context,” Journal of the National Cancer Institute Monographs, 1999, [retrieved from Internet].
Costantino et al. “Validation Studies for Models Predicting the Risk of Invasive and Total Breast Cancer Incidence,” Journal of National Cancer Institute, Sep. 15, 1999.
Archived version of the National Cancer Institute's Breast Cancer Risk Assessment Tool, Jun. 20, 2000 [archived on www.archive.org].
Hudson, Thomas “The human genome project: Tools for the identification of disease genes,” Clinical and Investigative Medicine, Dec. 1998, [retrieved from Proquest].
Khoury, Muin. “From genes to public health: The applications of genetic technology in disease prevention,” American Journal of Public Health, Dec. 1996, [retrieved from Proquest].
Hunter, David. “The future of molecular epidemiology,” International Journal of Epidemiology, Oct. 1999, [retrieved from Proquest].
Wade, Nicholas. “DNA chips join anti-cancer fight Devices monitor genetic mutations,” Denver Post, Apr. 8, 1997, [retrieved from Proquest].
Emilien et al. “Impact of genomics on drug discovery and clinical medicine,” Jul. 2000, [retrieved from Internet].
Sharp et al. “Involving study populations in the review of genetic research,” The Journal of Law, Medicine & Ethics, Spring 2000, [retrieved from Proquest].
Chow et al. “Effect of Tamoxifen on Mammographic Density,” Sep. 2000, [retrieved from Internet].
Slattery et al. “A comprehensive evaluation of family history and breast cancer risk.” Oct. 6, 1993, [retrieved from Internet].
Rosenthal et al. “Screening for Genetic Risk of Breast Cancer,” Jan. 1, 1999, [retrieved from Internet].
Spiegelman et al. “Validation of the Gail et al. model for predicting individual breast cancer risk.” Apr. 20, 1994, [retrieved from Internet].
Holtzman et al. “Final Report of the Task Force on Genetic Testing,” Sep. 1997, [retrieved from Internet].
“New Genetic Mutation Linked to Breast Cancer,” Doctor's Guide, Aug. 31, 1998, [retrieved from Internet].
Colditz et al. “Family history, age, and risk of breast cancer.” Jul. 21, 1993 [retrieved from Internet].
Ntais et al., “Meta-Analusis of the association of the Cathepsin D Ala224Val Gene Polymorphism with the Risk of Alzheimer's Disease: A HuGE Gene-Disease Association Review,” American Journal of Epidemiology, vol. 159 (2004), pp. 527-536.
Fowke et al., “Resistance to HIV-1 Infection Among Persistently Seronegative Prostitutes bin Nairobi, Kenya.”Lancet, England 348(9038):1347-1351, Nov. 16, 1996.
Olson, “Molecular Evolution '99 When Less is More: Gene Loss as an Engine of Evolutionary Change,”Am. J. Hum. Genet, 64:18-23, 1999.
Fowke, K. R. et al., Resistance to HIV-1 Infection Among Persistently Seronegative Prostitutes in Nairobl,, Kenya,The Lancet 348:1347-1351, 1996.
Lin, P. et al., NAD(P)H: Quinone Oxidoreductase Polymorphism and Lung Cancer in Taiwan,J. Toxicoloty and Environmental Health, Part A, 58187-197, 1999.
Lin, P. et al., NAD(P)H: Quinone Oxidoreductase Polymorphism and Lung Cancer in Taiwan,Journal of Toxicology and Environmental health, Part A, 58:187-197, 1999.
Drews, J., Genomic Sciences and the Medicine of Tomorrow,Nature Biotechnology 14:1516-1517, 1996.
Bumol, T. F. and Watanabe, A. M., Genetic Information, Genomic Technologies, and the Future of Drug Discovery,JAMA 285(5):551-555, 2001.
Dean et al.,Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene, Science (273):1856-1862, 1996.
Iadonato Shawn P.
Magness Charles L.
IB Security Holders LLC
K&L Gates LLP
Moran Marjorie
Skibinsky Anna
Winger C. Rachal
LandOfFree
System and method for selectively classifying a population does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with System and method for selectively classifying a population, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and System and method for selectively classifying a population will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2626208